During the past decade, Comprehensive Cancer Centers of Nevada-Summerlin conducted 129 clinical trials. In the 10-year time frame, 129 clinical trials started and 64 clinical trials were completed, i.e. on average, 49.6% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 48 clinical trials were completed. i.e. 104.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Comprehensive Cancer Centers of Nevada-Summerlin" #1 sponsor was "National Cancer Institute (NCI)" with 88 trials, followed by "SWOG Cancer Research Network" with 35 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Cancer Centers of Nevada-Summerlin" #1 collaborator was "National Cancer Institute (NCI)" with 85 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive Cancer Centers of Nevada-Summerlin" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (6 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (6 trials). Many other conditions were trialed in "Comprehensive Cancer Centers of Nevada-Summerlin" in a lesser frequency.

Most popular intervention types in "Comprehensive Cancer Centers of Nevada-Summerlin" are "Drug" (139 trials), "Other" (111 trials), "Biological" (76 trials), "Procedure" (47 trials) and "Radiation" (29 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (54 trials), "Quality-of-Life Assessment" (44 trials), "Computed Tomography" (29 trials), "Biospecimen Collection" (26 trials) and "Questionnaire Administration" (25 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Cancer Centers of Nevada-Summerlin" are 151 trials for "All" genders, 19 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Comprehensive Cancer Centers of Nevada-Summerlin". undefined are not yet recruiting, 46 are recruiting, 88 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Comprehensive Cancer Centers of Nevada-Summerlin, 5 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Cancer Centers of Nevada-Summerlin, 6 "Phase 1" clinical trials were conducted, 89 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".